Leading GMP cell CDMO I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the company has established low immunoreaction risk GMP ...

Leadership Perspective “Creative Medical is at the forefront of regenerative medicine, and our extended partnership with Greenstone Biosciences marks a significant milestone in our mission to develop ...

Scientists in China have manipulated embryonic stem cells to create laboratory mice with two male parents that managed to ...

Cynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs) verified ...

Researchers from the University of Illinois have identified a key process coordinating liver maturation and polyploidization, ...

Exosomes are gaining recognition for their potential applications in medicine, particularly in wound healing and inflammation reduction.

Novel approach designed to offer a more personalized and effective treatment option for patients suffering from diabetes and ...

Personalized medicine advances as autologous cell therapy grows, leveraging refined cell collection, improved processing ...

The fourth international congress of West Asian and North African (WANA) countries is scheduled to be held from May 3-4 in ...

Researchers will explore a promising approach for treating degenerative diseases by replacing damaged cells with new ones and ...

The concept of biological reproduction between same-sex individuals in mammals has always been deemed impossible. However, ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...